R-(+)-Lansoprazole

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

右兰索拉唑是一种质子泵抑制剂。

Dexlansoprazole is a Proton Pump Inhibitor. (In Vitro):The plasma concentrations of (R)-lansoprazole are remarkably higher in all three CYP2C19 genotype groups than those of the corresponding (S)-enantiomer. The AUC0-∞?Cmax?and elimination half-life of (R)-lansoprazole are significantly greater and longer, respectively, than those of the (S)-enantiomer for all three genotype groups.

The plasma concentrations of (R)-lansoprazole are remarkably higher in all three CYP2C19 genotype groups than those of the corresponding (S)-enantiomer. The AUC0-∞ Cmax and elimination half-life of (R)-lansoprazole are significantly greater and longer, respectively, than those of the (S)-enantiomer for all three genotype groups.

——

(+)-Lansoprazole | T-168390 | TAK-390

Membrane Transporter/Ion Channel

Proton Pump

Proton pump

Inflammation/Immunology

——

138530-94-6

369.36

C16H14F3N3O2S

>98% (HPLC)

Water: 74 mg/mL (200.34 mM); DMSO: 74 mg/mL (200.34 mM)

O=[S@@](C1=NC2=CC=CC=C2N1)CC3=NC=CC(OCC(F)(F)F)=C3C

(R)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole

(-20℃)

With Ice Pack

≥ 2 years